Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04442451 · ClinicalTrials.gov registry record · NA

Mechanisms of Fatigability With Diabetes

A NA study of Type 2 Diabetes and PreDiabetes, sponsored by University of Michigan.

Recruiting
Registry status
NA
Development phase
80
Enrollment target
1
Study location

NCT04442451: Recruiting NA study of Type 2 Diabetes and PreDiabetes, sponsored by University of Michigan.

NCT04442451 is a NA study of Type 2 Diabetes and PreDiabetes that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 80 participants, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04442451, a NA study of Type 2 Diabetes and PreDiabetes, is actively recruiting participants, sponsored by University of Michigan.

RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
1
Study location

Study Summary

Pre-diabetes (Pre-D) is a precursor to type 2 diabetes (T2D) and characterized by increased exercise fatigability of lower limb muscles, that can impede exercise performance. The cause for the increased fatigability in people with Pre-D is not known. Given the profound vascular disease present in people who have had uncontrolled diabetes for several years, we will determine whether dynamic, fatiguing contractions of the lower limb muscles in people with Pre-D are limited by vascular dysfunction at multiple levels along the vascular tree including the artery, arteriole, and/or capillary. This clinical trial involves a novel exercise training regime involving blood flow restriction to the exercising limb will be used as a probe to further understand the vascular mechanisms for increased fatigability in people with Pre-D and T2D. The long-term goal is to better understand what limits exercise and functional performance in people with diabetes to help develop targeted, more effective exercise programs.

Primary Outcome

Reduction in limb power and maximal force in response to a dynamic fatiguing contraction.

Interventions

  • OTHER Control Exercise
  • OTHER Blood Flow Restriction Exercise

Study Locations (1)

Michigan

  • University of Michigan - Ann Arbor

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2022-09-01
Est. Completion 2027-08-31
Phase NA
University of Michigan

1,327 total trials

What NCT04442451 shows while recruiting

NCT04442451 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 3,923-participant average among 327 other Type 2 Diabetes trials with a reported enrollment target (98% lower).

The record links to 2 conditions, with Type 2 Diabetes appearing as the primary indexed condition, and to 2 interventions - of which Control Exercise is the first listed.

NCT04442451 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT04442451 about?

NCT04442451 is a clinical study titled "Mechanisms of Fatigability With Diabetes". Pre-diabetes (Pre-D) is a precursor to type 2 diabetes (T2D) and characterized by increased exercise fatigability of lower limb muscles, that can impede exercise performance. The cause for the increased fatigability in people with Pre-D is not known. Given the profound vascular disease present in pe...

What is the current status of trial NCT04442451?

This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2022-09-01. Estimated completion is 2027-08-31.

What conditions does trial NCT04442451 study?

This clinical trial studies the following conditions: Type 2 Diabetes, PreDiabetes.

What interventions are being tested in trial NCT04442451?

The interventions under investigation include: Control Exercise (OTHER), Blood Flow Restriction Exercise (OTHER).

Who is sponsoring clinical trial NCT04442451?

This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04442451 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Type 2 Diabetes

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04442451's enrollment target sits among peer trials

80 175th of 327 higher than 150 of 327 other Type 2 Diabetes trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Type 2 Diabetes trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01243931 · 80 participants · NA

    Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy

  • NCT01659203 · 80 participants · Phase 1

    Proton or Photon RT for Retroperitoneal Sarcomas

  • NCT01803451 · 80 participants · Early Phase 1

    Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass

  • NCT01964859 · 80 participants · Phase 2

    Feasibility Study for Fibroblast Autologous Skin Grafts

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04442451, the US trial registry maintained by the National Library of Medicine. NCT04442451 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.